Form EFFECT LUMOS PHARMA, INC.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 12, 2024 |
| Accession Number: | 0001193125-24-276556 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- muVpix Original Swipe Left: Dying for Love Named Vertical of the Year as Platform Launches Romeo & Juliet, Reimagined
- Sogang University Opens a Full-Tuition Path for International STEM Graduate Students in Seoul
- Tuya Reports Second Quarter 2026 Unaudited Financial Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
